Anebulo Pharmaceuticals
ANEB
ANEB
9 hedge funds and large institutions have $28.7M invested in Anebulo Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 9 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
9
Holders Change
+9
Holders Change %
–
% of All Funds
0.16%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
9
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
2L
22NW LP
Seattle,
Washington
|
+$22.8M |
| 2 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
+$2.92M |
| 3 |
LCM
Laurion Capital Management
New York
|
+$1.55M |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
+$1.2M |
| 5 |
BFM
Boothbay Fund Management
New York
|
+$135K |
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
2L
1
22NW LP
Seattle,
Washington
| $22.8M | +$22.8M | +3,343,565 | New |
|
|
MP
2
Mangrove Partners
Greenwich,
Connecticut
| $2.92M | +$2.92M | +428,500 | New |
|
|
LCM
3
Laurion Capital Management
New York
| $1.55M | +$1.55M | +225,000 | New |
|
|
IC
4
Ikarian Capital
Dallas,
Texas
| $1.2M | +$1.2M | +174,811 | New |
|
|
BFM
5
Boothbay Fund Management
New York
| $135K | +$135K | +19,835 | New |
|
6
BlackRock
New York
| $53K | +$53K | +7,773 | New |
|
7
UBS Group
Zurich,
Switzerland
| $2K | +$2K | +234 | New |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| $1K | +$1K | +158 | New |
|